MAIN Trial: Effectiveness of Mycophenolate Mofetil Among Patients With Progressive IgA Nephropathy - A Randomized Clinical Trial ca. 2023 from @JAMA_current #Nephpearls #NephJC #VisualAbstract by @meyyappannephro https://t.co/QLZmuQOyYf https://t.co/HVM4Qv4aHC
Effectiveness of Mycophenolate Mofetil Among Patients With Progressive IgA Nephropathy: A Randomized Clinical Trial.
Mentions
Extended reach
Total likes
Video views
Mentions per month
Feb 2023 – May 2025Where it's discussed
-
X / Twitter143 posts
-
Blogs5 articles
-
News3 articles
-
YouTube2 videos
-
Facebook2 posts
-
Bluesky1 posts
AI synopsis
What people are saying
Many discussions focus on the effectiveness of Mycophenolate Mofetil (MMF) for patients with progressive IgA nephropathy, highlighting its potential to reduce renal worsening. Comments such as 'What exciting findings!' and 'options are increasing' reveal enthusiasm and optimism about the advancements in treatment. The tone of the discussions is largely positive, suggesting a keen interest in the wider implications of the study, which enhances the overall perception of the research's importance.
The majority of discussions reflect a general support for the findings presented in the publication.
Participants show a high level of curiosity, as indicated by the numerous requests for summaries and additional information.
While some posts merely share links, several contributors delve into the specifics of the findings, indicating a moderate depth of engagement.
The impact is perceived as significant, with many discussing the potential implications of the research for treatment options.
Abstract in brief
- The study investigates the effectiveness of Mycophenolate Mofetil (MMF) in treating patients with progressive IgA nephropathy (IgAN), a kidney condition that can lead to kidney failure.
- Researchers conducted a randomized clinical trial involving 170 adults, comparing MMF plus supportive care (SC) to SC alone over a three-year period.
- Results showed that MMF treatment did not significantly improve primary outcomes related to kidney health progression compared to supportive care alone, indicating the need for further research on MMF's role in IgAN management.
Top posts
Most liked on X and BlueskyEn nefropatía por IgA de alto riesgo, micofenolato de mofetilo 1.5gr con descenso durante 1.5 años, comparado a lo habitual, ↓~75% los eventos renales y el riesgo de progresión. Ensayo clínico MAIN #ISNyoung JAMA Network Open 2023 doi:10.1001/jamanetworkopen.2022.54054 https://t.co/EQIF6vNsxU
Effectiveness of Mycophenolate Mofetil Among Patients With Progressive IgA Nephropathy: options are increasing
An open-label trial of 170 adults w/ IgA Nephropathy (proteinuria >1 g/d) evaluated addition of mycophenolate to standard care (SC). MMF (1.5g/d) associated w/ less renal worsening - 7.1% MMF + SC vs. 21% SC alone (aHR 0.23; 95% CI, 0.09-0.63) https://t.co/FlcafoZi3U https://t.co/tQkZE8RRyy
Good evening! Tonight we will be discussing the paper: Effectiveness of Mycophenolate Mofetil Among Patients With Progressive IgA Nephropathy #NephJC https://t.co/93sKHnFKP1
Effectiveness of Mycophenolate Mofetil Among Patients With Progressive IgA Nephropathy A Randomized Clinical Trial https://t.co/eGKAv7zaq0
All mentions
Innovative Treatments for IgA Nephropathy Explained
In this video, Prof. Dr. Jürgen Floege discusses established and innovative therapies for IgA nephropathy. Recent clinical trials reveal promising results for treatments like methylprednisolone, showing significant…
Key Insights on IgA Nephropathy and Methylprednisolone Treatment
In this episode, Koyal and Kenar recap essential knowledge about IgA nephropathy (IgAN) for board examinations and treatment decisions. Emphasizing a recent study, they reveal that methylprednisolone reduces serious…
#AulasAbiertasUdeA | Effectiveness of mycophenolate mofetil among patients with progressive IgA nephropathy -Por: Dra. Paola Mera
In the next few tweets, I will summarise other agents, some new, some old. Let's start with #MMF. This is a single-centre study with 170 participants. VA by @meyyappannephro https://t.co/Z4nyNZKFDw https://t.co/hJtEi0eWXp
Attending #KidneyWk? Supplement your schedule with Effectiveness of Mycophenolate Mofetil Among Patients With Progressive IgA Nephropathy: A Randomized Clinical Trial, from @JAMANetworkOpen. Free to read online https://t.co/sWFOF9uFkB https://t.co/mVQ17jWCBI
Attending #KidneyWk? Supplement your schedule with Effectiveness of Mycophenolate Mofetil Among Patients With Progressive IgA Nephropathy: A Randomized Clinical Trial, from JAMA Network Open. Free to read online https://t.co/m3D4j6ScNU https://t.co/6Qwm5YAfrg
RT @edgarvlermamd: MAIN Trial: Effectiveness of Mycophenolate Mofetil Among Patients With Progressive IgA Nephropathy - A Randomized Clinic…
2/10 What did I miss? We reviewed the recent article in JAMA Network Open “Effectiveness of Mycophenolate Mofetil Among Patients With Progressive IgA Nephropathy: A Randomized Clinical Trial”. https://t.co/93sKHnGiEz
RT @edgarvlermamd: MAIN Trial: Effectiveness of Mycophenolate Mofetil Among Patients With Progressive IgA Nephropathy - A Randomized Clinic…
RT @edgarvlermamd: MAIN Trial: Effectiveness of Mycophenolate Mofetil Among Patients With Progressive IgA Nephropathy - A Randomized Clinic…
RT @NephJC: We will discuss the MAIN study: Effectiveness of Mycophenolate Mofetil Among Patients With Progressive IgA Nephropathy #NephJC…
RT @edgarvlermamd: MAIN Trial: Effectiveness of Mycophenolate Mofetil Among Patients With Progressive IgA Nephropathy - A Randomized Clinic…
RT @edgarvlermamd: MAIN Trial: Effectiveness of Mycophenolate Mofetil Among Patients With Progressive IgA Nephropathy - A Randomized Clinic…
RT @edgarvlermamd: MAIN Trial: Effectiveness of Mycophenolate Mofetil Among Patients With Progressive IgA Nephropathy - A Randomized Clinic…
RT @edgarvlermamd: MAIN Trial: Effectiveness of Mycophenolate Mofetil Among Patients With Progressive IgA Nephropathy - A Randomized Clinic…
RT @edgarvlermamd: MAIN Trial: Effectiveness of Mycophenolate Mofetil Among Patients With Progressive IgA Nephropathy - A Randomized Clinic…
RT @edgarvlermamd: MAIN Trial: Effectiveness of Mycophenolate Mofetil Among Patients With Progressive IgA Nephropathy - A Randomized Clinic…
RT @edgarvlermamd: MAIN Trial: Effectiveness of Mycophenolate Mofetil Among Patients With Progressive IgA Nephropathy - A Randomized Clinic…
RT @nephroblog: Effectiveness of Mycophenolate Mofetil Among Patients With Progressive IgA Nephropathy: A Randomized Clinical Trial | Chron…
Effectiveness of Mycophenolate Mofetil Among Patients With Progressive IgA Nephropathy: A Randomized Clinical Trial | Chronic Kidney Disease | JAMA Network Open | JAMA Network https://t.co/Mv9UeEfZKu
RT @edgarvlermamd: MAIN Trial: Effectiveness of Mycophenolate Mofetil Among Patients With Progressive IgA Nephropathy - A Randomized Clinic…
RT @edgarvlermamd: MAIN Trial: Effectiveness of Mycophenolate Mofetil Among Patients With Progressive IgA Nephropathy - A Randomized Clinic…
RT @edgarvlermamd: MAIN Trial: Effectiveness of Mycophenolate Mofetil Among Patients With Progressive IgA Nephropathy - A Randomized Clinic…
RT @edgarvlermamd: MAIN Trial: Effectiveness of Mycophenolate Mofetil Among Patients With Progressive IgA Nephropathy - A Randomized Clinic…
RT @NephJC: We will discuss the MAIN study: Effectiveness of Mycophenolate Mofetil Among Patients With Progressive IgA Nephropathy #NephJC…
We will discuss the MAIN study: Effectiveness of Mycophenolate Mofetil Among Patients With Progressive IgA Nephropathy #NephJC https://t.co/93sKHnFKP1
RT @NephJC: Good evening! Tonight we will be discussing the paper: Effectiveness of Mycophenolate Mofetil Among Patients With Progressive I…
RT @NephJC: Good evening! Tonight we will be discussing the paper: Effectiveness of Mycophenolate Mofetil Among Patients With Progressive I…
RT @NephJC: Good evening! Tonight we will be discussing the paper: Effectiveness of Mycophenolate Mofetil Among Patients With Progressive I…
Good evening! Tonight we will be discussing the paper: Effectiveness of Mycophenolate Mofetil Among Patients With Progressive IgA Nephropathy #NephJC https://t.co/93sKHnFKP1
RT @edgarvlermamd: MAIN Trial: Effectiveness of Mycophenolate Mofetil Among Patients With Progressive IgA Nephropathy - A Randomized Clinic…
RT @edgarvlermamd: MAIN Trial: Effectiveness of Mycophenolate Mofetil Among Patients With Progressive IgA Nephropathy - A Randomized Clinic…
RT @edgarvlermamd: MAIN Trial: Effectiveness of Mycophenolate Mofetil Among Patients With Progressive IgA Nephropathy - A Randomized Clinic…
RT @edgarvlermamd: MAIN Trial: Effectiveness of Mycophenolate Mofetil Among Patients With Progressive IgA Nephropathy - A Randomized Clinic…
RT @edgarvlermamd: MAIN Trial: Effectiveness of Mycophenolate Mofetil Among Patients With Progressive IgA Nephropathy - A Randomized Clinic…
RT @edgarvlermamd: MAIN Trial: Effectiveness of Mycophenolate Mofetil Among Patients With Progressive IgA Nephropathy - A Randomized Clinic…
RT @edgarvlermamd: MAIN Trial: Effectiveness of Mycophenolate Mofetil Among Patients With Progressive IgA Nephropathy - A Randomized Clinic…
RT @edgarvlermamd: MAIN Trial: Effectiveness of Mycophenolate Mofetil Among Patients With Progressive IgA Nephropathy - A Randomized Clinic…
RT @edgarvlermamd: MAIN Trial: Effectiveness of Mycophenolate Mofetil Among Patients With Progressive IgA Nephropathy - A Randomized Clinic…
RT @edgarvlermamd: MAIN Trial: Effectiveness of Mycophenolate Mofetil Among Patients With Progressive IgA Nephropathy - A Randomized Clinic…
RT @edgarvlermamd: MAIN Trial: Effectiveness of Mycophenolate Mofetil Among Patients With Progressive IgA Nephropathy - A Randomized Clinic…
RT @edgarvlermamd: MAIN Trial: Effectiveness of Mycophenolate Mofetil Among Patients With Progressive IgA Nephropathy - A Randomized Clinic…
RT @edgarvlermamd: MAIN Trial: Effectiveness of Mycophenolate Mofetil Among Patients With Progressive IgA Nephropathy - A Randomized Clinic…
RT @edgarvlermamd: MAIN Trial: Effectiveness of Mycophenolate Mofetil Among Patients With Progressive IgA Nephropathy - A Randomized Clinic…
RT @edgarvlermamd: MAIN Trial: Effectiveness of Mycophenolate Mofetil Among Patients With Progressive IgA Nephropathy - A Randomized Clinic…
RT @edgarvlermamd: MAIN Trial: Effectiveness of Mycophenolate Mofetil Among Patients With Progressive IgA Nephropathy - A Randomized Clinic…
RT @edgarvlermamd: MAIN Trial: Effectiveness of Mycophenolate Mofetil Among Patients With Progressive IgA Nephropathy - A Randomized Clinic…
RT @edgarvlermamd: MAIN Trial: Effectiveness of Mycophenolate Mofetil Among Patients With Progressive IgA Nephropathy - A Randomized Clinic…
RT @edgarvlermamd: MAIN Trial: Effectiveness of Mycophenolate Mofetil Among Patients With Progressive IgA Nephropathy - A Randomized Clinic…
RT @edgarvlermamd: MAIN Trial: Effectiveness of Mycophenolate Mofetil Among Patients With Progressive IgA Nephropathy - A Randomized Clinic…
RT @edgarvlermamd: MAIN Trial: Effectiveness of Mycophenolate Mofetil Among Patients With Progressive IgA Nephropathy - A Randomized Clinic…
RT @edgarvlermamd: MAIN Trial: Effectiveness of Mycophenolate Mofetil Among Patients With Progressive IgA Nephropathy - A Randomized Clinic…
RT @edgarvlermamd: MAIN Trial: Effectiveness of Mycophenolate Mofetil Among Patients With Progressive IgA Nephropathy - A Randomized Clinic…
MAIN Trial: Effectiveness of Mycophenolate Mofetil Among Patients With Progressive IgA Nephropathy - A Randomized Clinical Trial ca. 2023 from @JAMA_current #Nephpearls #NephJC #VisualAbstract by @meyyappannephro https://t.co/QLZmuQOyYf https://t.co/HVM4Qv4aHC
Welcome, all! Tonight will be discussing the MAIN trial. Link here: https://t.co/93sKHnFKP1 #NephJC
RT @NephJC: Looking forward to the next NephJC discussion in 2 weeks https://t.co/93sKHnFKP1 Stay tuned! Don’t forget to sign up for NephJ…
Looking forward to the next NephJC discussion in 2 weeks https://t.co/93sKHnFKP1 Stay tuned! Don’t forget to sign up for NephJC newsletter https://t.co/Sm1AmzpSld #NephJC
RT @kdjhaveri: Effectiveness of Mycophenolate Mofetil Among Patients With Progressive IgA Nephropathy: A Randomized Clinical Trial @JAMAIn…
RT @JonathanNefro: En nefropatía por IgA de alto riesgo, micofenolato de mofetilo 1.5gr con descenso durante 1.5 años, comparado a lo habit…
RT @kdjhaveri: Effectiveness of Mycophenolate Mofetil Among Patients With Progressive IgA Nephropathy: A Randomized Clinical Trial @JAMAIn…
RT @JonathanNefro: En nefropatía por IgA de alto riesgo, micofenolato de mofetilo 1.5gr con descenso durante 1.5 años, comparado a lo habit…
RT @kdjhaveri: Effectiveness of Mycophenolate Mofetil Among Patients With Progressive IgA Nephropathy: A Randomized Clinical Trial @JAMAIn…
What an exciting time for therapeutics in IgA Nephropathy. https://t.co/MSIYqkGLmS
RT @JonathanNefro: En nefropatía por IgA de alto riesgo, micofenolato de mofetilo 1.5gr con descenso durante 1.5 años, comparado a lo habit…
RT @JonathanNefro: En nefropatía por IgA de alto riesgo, micofenolato de mofetilo 1.5gr con descenso durante 1.5 años, comparado a lo habit…
Effectiveness of Mycophenolate Mofetil Among Patients With Progressive IgA Nephropathy: A Randomized Clinical Trial - PubMed https://t.co/HM8KwgG68E
RT @BondGregor: Effectiveness of Mycophenolate Mofetil Among Patients With Progressive IgA Nephropathy: options are increasing
RT @BondGregor: Effectiveness of Mycophenolate Mofetil Among Patients With Progressive IgA Nephropathy: options are increasing
RT @BondGregor: Effectiveness of Mycophenolate Mofetil Among Patients With Progressive IgA Nephropathy: options are increasing
RT @BondGregor: Effectiveness of Mycophenolate Mofetil Among Patients With Progressive IgA Nephropathy: options are increasing
RT @BondGregor: Effectiveness of Mycophenolate Mofetil Among Patients With Progressive IgA Nephropathy: options are increasing
RT @BondGregor: Effectiveness of Mycophenolate Mofetil Among Patients With Progressive IgA Nephropathy: options are increasing
RT @abdelhamed012: Effectiveness of Mycophenolate Mofetil Among Patients With Progressive IgA Nephropathy A Randomized Clinical Trial https…
RT @abdelhamed012: Effectiveness of Mycophenolate Mofetil Among Patients With Progressive IgA Nephropathy A Randomized Clinical Trial https…
Effectiveness of Mycophenolate Mofetil Among Patients With Progressive IgA Nephropathy https://t.co/JXMqZEdG3P via @JAMANetworkOpen part of @JAMANetwork
RT @BondGregor: Effectiveness of Mycophenolate Mofetil Among Patients With Progressive IgA Nephropathy: options are increasing
Effectiveness of Mycophenolate Mofetil Among Patients With Progressive IgA Nephropathy: options are increasing
RT @abdelhamed012: Effectiveness of Mycophenolate Mofetil Among Patients With Progressive IgA Nephropathy A Randomized Clinical Trial https…
Effectiveness of Mycophenolate Mofetil Among Patients With Progressive IgA Nephropathy A Randomized Clinical Trial https://t.co/eGKAv7zaq0
RT @mapefer3: Nuevo ensayo clínico que evalúa la eficacia de MMF vs tratamiento de soporte. https://t.co/RquA7cLJxP
RT @satoshi_1022: IgA腎症に対するミコフェノール酸モフェチル、単施設RCT。 まだ細かく読んでないけど、良さそう。 Effectiveness of Mycophenolate Mofetil Among Patients With Progressive…
RT @satoshi_1022: IgA腎症に対するミコフェノール酸モフェチル、単施設RCT。 まだ細かく読んでないけど、良さそう。 Effectiveness of Mycophenolate Mofetil Among Patients With Progressive…
IgA腎症に対するミコフェノール酸モフェチル、単施設RCT。 まだ細かく読んでないけど、良さそう。 Effectiveness of Mycophenolate Mofetil Among Patients With Progressive IgA Nephropathy https://t.co/vN7zYLv5n4 @JAMANetworkOpen part of @JAMANetworkより
RT @RheumNow: An open-label trial of 170 adults w/ IgA Nephropathy (proteinuria >1 g/d) evaluated addition of mycophenolate to standard car…
An open-label trial of 170 adults w/ IgA Nephropathy (proteinuria >1 g/d) evaluated addition of mycophenolate to standard care (SC). MMF (1.5g/d) associated w/ less renal worsening - 7.1% MMF + SC vs. 21% SC alone (aHR 0.23; 95% CI, 0.09-0.63) https://t.co/FlcafoZi3U https://t.co/tQkZE8RRyy
RT @JonathanNefro: En nefropatía por IgA de alto riesgo, micofenolato de mofetilo 1.5gr con descenso durante 1.5 años, comparado a lo habit…
RT @iqraakidneycare: Effectiveness of Mycophenolate Mofetil Among Patients With Progressive IgA Nephropathy: A Randomized Clinical Trial |…
Effectiveness of Mycophenolate Mofetil Among Patients With Progressive IgA Nephropathy: A Randomized Clinical Trial | Chronic Kidney Disease | JAMA Network Open | JAMA Network @nkf @renalandurology https://t.co/kHG4ifPGy6
Nuevo ensayo clínico que evalúa la eficacia de MMF vs tratamiento de soporte. https://t.co/RquA7cLJxP
RT @JonathanNefro: En nefropatía por IgA de alto riesgo, micofenolato de mofetilo 1.5gr con descenso durante 1.5 años, comparado a lo habit…
RT @kdjhaveri: Effectiveness of Mycophenolate Mofetil Among Patients With Progressive IgA Nephropathy: A Randomized Clinical Trial @JAMAIn…
RT @JonathanNefro: En nefropatía por IgA de alto riesgo, micofenolato de mofetilo 1.5gr con descenso durante 1.5 años, comparado a lo habit…
RT @JonathanNefro: En nefropatía por IgA de alto riesgo, micofenolato de mofetilo 1.5gr con descenso durante 1.5 años, comparado a lo habit…
RT @JonathanNefro: En nefropatía por IgA de alto riesgo, micofenolato de mofetilo 1.5gr con descenso durante 1.5 años, comparado a lo habit…
RT @JonathanNefro: En nefropatía por IgA de alto riesgo, micofenolato de mofetilo 1.5gr con descenso durante 1.5 años, comparado a lo habit…
RT @JonathanNefro: En nefropatía por IgA de alto riesgo, micofenolato de mofetilo 1.5gr con descenso durante 1.5 años, comparado a lo habit…
RT @JonathanNefro: En nefropatía por IgA de alto riesgo, micofenolato de mofetilo 1.5gr con descenso durante 1.5 años, comparado a lo habit…
RT @JonathanNefro: En nefropatía por IgA de alto riesgo, micofenolato de mofetilo 1.5gr con descenso durante 1.5 años, comparado a lo habit…
RT @JonathanNefro: En nefropatía por IgA de alto riesgo, micofenolato de mofetilo 1.5gr con descenso durante 1.5 años, comparado a lo habit…
RT @JonathanNefro: En nefropatía por IgA de alto riesgo, micofenolato de mofetilo 1.5gr con descenso durante 1.5 años, comparado a lo habit…
RT @JonathanNefro: En nefropatía por IgA de alto riesgo, micofenolato de mofetilo 1.5gr con descenso durante 1.5 años, comparado a lo habit…
RT @kdjhaveri: Effectiveness of Mycophenolate Mofetil Among Patients With Progressive IgA Nephropathy: A Randomized Clinical Trial @JAMAIn…
RT @JonathanNefro: En nefropatía por IgA de alto riesgo, micofenolato de mofetilo 1.5gr con descenso durante 1.5 años, comparado a lo habit…
RT @JonathanNefro: En nefropatía por IgA de alto riesgo, micofenolato de mofetilo 1.5gr con descenso durante 1.5 años, comparado a lo habit…
RT @JonathanNefro: En nefropatía por IgA de alto riesgo, micofenolato de mofetilo 1.5gr con descenso durante 1.5 años, comparado a lo habit…
RT @kdjhaveri: Effectiveness of Mycophenolate Mofetil Among Patients With Progressive IgA Nephropathy: A Randomized Clinical Trial @JAMAIn…
RT @JonathanNefro: En nefropatía por IgA de alto riesgo, micofenolato de mofetilo 1.5gr con descenso durante 1.5 años, comparado a lo habit…
RT @JonathanNefro: En nefropatía por IgA de alto riesgo, micofenolato de mofetilo 1.5gr con descenso durante 1.5 años, comparado a lo habit…
RT @JonathanNefro: En nefropatía por IgA de alto riesgo, micofenolato de mofetilo 1.5gr con descenso durante 1.5 años, comparado a lo habit…
RT @kdjhaveri: Effectiveness of Mycophenolate Mofetil Among Patients With Progressive IgA Nephropathy: A Randomized Clinical Trial @JAMAIn…
RT @JonathanNefro: En nefropatía por IgA de alto riesgo, micofenolato de mofetilo 1.5gr con descenso durante 1.5 años, comparado a lo habit…
RT @iqraakidneycare: Effectiveness of Mycophenolate Mofetil Among Patients With Progressive IgA Nephropathy: A Randomized Clinical Trial |…
RT @JonathanNefro: En nefropatía por IgA de alto riesgo, micofenolato de mofetilo 1.5gr con descenso durante 1.5 años, comparado a lo habit…
RT @JonathanNefro: En nefropatía por IgA de alto riesgo, micofenolato de mofetilo 1.5gr con descenso durante 1.5 años, comparado a lo habit…
RT @JonathanNefro: En nefropatía por IgA de alto riesgo, micofenolato de mofetilo 1.5gr con descenso durante 1.5 años, comparado a lo habit…
RT @JonathanNefro: En nefropatía por IgA de alto riesgo, micofenolato de mofetilo 1.5gr con descenso durante 1.5 años, comparado a lo habit…
En nefropatía por IgA de alto riesgo, micofenolato de mofetilo 1.5gr con descenso durante 1.5 años, comparado a lo habitual, ↓~75% los eventos renales y el riesgo de progresión. Ensayo clínico MAIN #ISNyoung JAMA Network Open 2023 doi:10.1001/jamanetworkopen.2022.54054 https://t.co/EQIF6vNsxU
RT @kdjhaveri: Effectiveness of Mycophenolate Mofetil Among Patients With Progressive IgA Nephropathy: A Randomized Clinical Trial @JAMAIn…
RT @iqraakidneycare: Effectiveness of Mycophenolate Mofetil Among Patients With Progressive IgA Nephropathy: A Randomized Clinical Trial |…
RT @kdjhaveri: Effectiveness of Mycophenolate Mofetil Among Patients With Progressive IgA Nephropathy: A Randomized Clinical Trial @JAMAIn…
RT @kdjhaveri: Effectiveness of Mycophenolate Mofetil Among Patients With Progressive IgA Nephropathy: A Randomized Clinical Trial @JAMAIn…
RT @iqraakidneycare: Effectiveness of Mycophenolate Mofetil Among Patients With Progressive IgA Nephropathy: A Randomized Clinical Trial |…
Interesting findings MMF effective in IgA nephropathy in a specific population Effectiveness of Mycophenolate Mofetil Among Patients With Progressive IgA Nephropathy https://t.co/SXPztJ5svG via @JAMANetworkOpen part of @JAMANetwork
RT @Renaltubules: Question: What is a effectiveness of Mycophenolate Mofetil in reducing progression in progressive IgA Nephropathy Ans: M…
RT @iqraakidneycare: Effectiveness of Mycophenolate Mofetil Among Patients With Progressive IgA Nephropathy: A Randomized Clinical Trial |…
RT @kdjhaveri: Effectiveness of Mycophenolate Mofetil Among Patients With Progressive IgA Nephropathy: A Randomized Clinical Trial @JAMAIn…
RT @kdjhaveri: Effectiveness of Mycophenolate Mofetil Among Patients With Progressive IgA Nephropathy: A Randomized Clinical Trial @JAMAIn…
RT @iqraakidneycare: Effectiveness of Mycophenolate Mofetil Among Patients With Progressive IgA Nephropathy: A Randomized Clinical Trial |…
RT @kdjhaveri: Effectiveness of Mycophenolate Mofetil Among Patients With Progressive IgA Nephropathy: A Randomized Clinical Trial @JAMAIn…
Effectiveness of Mycophenolate Mofetil Among Patients With Progressive IgA Nephropathy https://t.co/pZBE9PyDHo vía @JAMANetworkOpen part of @JAMANetwork
RT @Renaltubules: Question: What is a effectiveness of Mycophenolate Mofetil in reducing progression in progressive IgA Nephropathy Ans: M…
RT @kdjhaveri: Effectiveness of Mycophenolate Mofetil Among Patients With Progressive IgA Nephropathy: A Randomized Clinical Trial @JAMAIn…
Effectiveness of Mycophenolate Mofetil Among Patients With Progressive IgA Nephropathy #Nephpearls #IgA https://t.co/GqqWlsGUpk https://t.co/Ag3fLmBR8P
RT @iqraakidneycare: Effectiveness of Mycophenolate Mofetil Among Patients With Progressive IgA Nephropathy: A Randomized Clinical Trial |…
RT @Renaltubules: Question: What is a effectiveness of Mycophenolate Mofetil in reducing progression in progressive IgA Nephropathy Ans: M…
RT @kdjhaveri: Effectiveness of Mycophenolate Mofetil Among Patients With Progressive IgA Nephropathy: A Randomized Clinical Trial @JAMAIn…
進行したIgA腎症に対するMMFの有効性 JAMA Network Open https://t.co/VHuiw9nDCT
RT @Renaltubules: Question: What is a effectiveness of Mycophenolate Mofetil in reducing progression in progressive IgA Nephropathy Ans: M…
RT @Renaltubules: Question: What is a effectiveness of Mycophenolate Mofetil in reducing progression in progressive IgA Nephropathy Ans: M…
RT @kdjhaveri: Effectiveness of Mycophenolate Mofetil Among Patients With Progressive IgA Nephropathy: A Randomized Clinical Trial @JAMAIn…
RT @kdjhaveri: Effectiveness of Mycophenolate Mofetil Among Patients With Progressive IgA Nephropathy: A Randomized Clinical Trial @JAMAIn…
RT @kdjhaveri: Effectiveness of Mycophenolate Mofetil Among Patients With Progressive IgA Nephropathy: A Randomized Clinical Trial @JAMAIn…
RT @kdjhaveri: Effectiveness of Mycophenolate Mofetil Among Patients With Progressive IgA Nephropathy: A Randomized Clinical Trial @JAMAIn…
RT @iqraakidneycare: Effectiveness of Mycophenolate Mofetil Among Patients With Progressive IgA Nephropathy: A Randomized Clinical Trial |…
Effectiveness of Mycophenolate Mofetil Among Patients With Progressive IgA Nephropathy: A Randomized Clinical Trial @JAMAInternalMed https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2800997